Werner Spinner, a non-executive director at the stem cell bank group Cryo-Save, has topped up his stake in the company, taking about £20,000 worth of shares.
Spinner, who served for 30 years with the German drug giant Bayer, took 25,000 shares at 77.2p a time.
He now has 284,868 shares or about 0.6% of Cryo-Save.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Cryo-Save, which has its headquarters in the Netherlands and stores more than 100,000 adult stem cells in storage facilities in Belgium, Germany and Dubai, last month reported a fall in full-year profits due to higher operating expenses, but said it was well positioned to capitalise on its international position.
Revenue was up 67% to €29.5m in the year ended 31 December, while pre-tax profit fell to €2.86m compared with €4.51m last time as operating expenses rose to €17.9m from €7.13m previously.
Top Director Buys
Value: £49,980
Value: £19,740
Value: £19,300
Value: $12,000
Value: £10,183
Top Director Sells
Value: £2,400,000
Value: £2,400,000
Value: £960,000
Value: £321,922
Value: £119,138
Value: £53,472
Value: £41,736
Value: £38,244
Value: £35,123
Value: £12,000
-
The top stocks in the FTSE 100After a year of strong returns for the UK’s flagship index, which FTSE 100 stocks have posted the best performance in 2024?
-
A junior ISA could turn your child’s pocket money into thousands of poundsPersuading your child to put their pocket money in a junior ISA might be difficult, but the pennies could quickly grow into pounds – and teach them a valuable lesson about money
